Friday, August 18, 2017 10:15 PM ET
Significant Insider purchase of Xencor (XNCR) Shares Extends the Buying Trend of Last Quarter
Substantial insider buying activity was disclosed in Xencor shares in a form 4 document filed with the SEC today, showing — John S Stafford III, 10% Owner — purchased 147,535 shares in the company having a net market value of approximately $3,008,406. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 34,500 company shares and the disposition of 22,366 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 159,669 shares and have averaged 68,134 shares per transaction over this time period.
The number of insider buy/sell trades at Xencor is above that of the 263 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 315 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Xencor insiders is lower than its peers. Within the peer group there were 8,002,921 shares purchased and 14,221,665 shares sold with company insiders disposing of 19,742 shares on average over this time period.
The data sourced in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.